Pages that link to "Q49019860"

The following pages link to Eduard Bentea (Q49019860):

Displaying 27 items.

• Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein (Q30633819) (← links)
• Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis (Q37586538) (← links)
• Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor. (Q37729142) (← links)
• The Proteasome Inhibition Model of Parkinson's Disease (Q38996038) (← links)
• Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed (Q40400682) (← links)
• MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT. (Q41232424) (← links)
• Lack of effect of Theiler's murine encephalomyelitis virus infection on system xc⁻. (Q41398493) (← links)
• Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc. (Q42503524) (← links)
• In-depth behavioral characterization of the corticosterone mouse model and the critical involvement of housing conditions. (Q47585703) (← links)
• Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision. (Q47683896) (← links)
• Selective changes in locomotor activity in mice due to low-intensity microwaves amplitude modulated in the EEG spectral domain. (Q47711907) (← links)
• Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model (Q47775588) (← links)
• The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain (Q47852091) (← links)
• Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease. (Q47962017) (← links)
• Disruption of the HPA-axis through corticosterone-release pellets induces robust depressive-like behavior and reduced BDNF levels in mice (Q48054792) (← links)
• Altered vesicular glutamate transporter expression in human temporal lobe epilepsy with hippocampal sclerosis (Q48335704) (← links)
• Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice (Q49019743) (← links)
• Validation of the 6 Hz refractory seizure mouse model for intracerebroventricularly administered compounds. (Q51830195) (← links)
• Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease. (Q52152099) (← links)
• Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice. (Q52564304) (← links)
• Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson's Disease (Q57072471) (← links)
• Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia (Q64057124) (← links)
• Erratum to "Selective Changes in Locomotor Activity in Mice Due to Low-intensity Microwaves Amplitude Modulated in the EEG Spectral Domain" [Neuroscience 359 (2017) 40-48] (Q90251162) (← links)
• Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway (Q90766342) (← links)
• Anticonvulsant and antiepileptogenic effects of system xc- inactivation in chronic epilepsy models (Q92622206) (← links)
• Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter (Q94521596) (← links)
• Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway (Q112346286) (← links)